|
Dr. Parker has 12 years of healthcare consulting experience centered on the intersection of reimbursement, health economics, clinical science, and marketing strategy. For more than 10 years preceding his appointment, he was a senior consulting executive at Covance Market Access Services, where as a Vice President he led the Economic Strategies and Devices and Diagnostics practices. During this period, he delivered hundreds of consulting engagements for pharmaceutical, biotechnology, medical device, and diagnostics clients. His consulting encompasses all aspects of reimbursement and market strategy development with a particular focus on medical devices, molecular diagnostics, and personalized medicine. Dr. Parker's work has resulted in numerous successful product launches and favorable coverage and payment decisions by public and private payers alike. Dr. Parker received a Ph.D. in Cell and Developmental Biology from the Massachusetts Institute of Technology, where he was a National Science Foundation Fellow, and an A.B. with high honors from Princeton University. | 